BIEL's "past unsavory happenings" were all pies in the sky first, just like this NOPAIN Buyout story. NHS, FDA OTC clearance, OEM Partners, and Synergy were all slam dunks that couldn't fail to make investors rich. Except they failed. When a company has such a consistent record of failure, it's unwise to get excited about this NOPAIN pie in the sky, or the next pie in the sky, or the one after that.....
"Yeah, but this time it's different." Is it really?